Rosivo is a development stage medical device company with patented technologies for producing refined biological implants. We are guided by a team of accomplished investors, scientific leaders, and experienced business advisors. Our Mission: Many indications exist in which biomaterial therapies could provide improved outcomes while possessing a faster route to market and significantly reduced cost compared to cell-based therapies. Rosivo aims to develop refined biomaterial therapies to treat these indications.